[HTML][HTML] Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis
SR Ytterberg, DL Bhatt, TR Mikuls… - … England Journal of …, 2022 - Mass Medical Soc
Background Increases in lipid levels and cancers with tofacitinib prompted a trial of major
adverse cardiovascular events (MACE) and cancers in patients with rheumatoid arthritis …
adverse cardiovascular events (MACE) and cancers in patients with rheumatoid arthritis …
[PDF][PDF] Postapproval comparative safety study of tofacitinib and biological Disease‐Modifying Antirheumatic drugs: 5‐Year results from a United States–based …
JM Kremer, CO Bingham III, LC Cappelli… - ACR Open …, 2021 - Wiley Online Library
Objective Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis
(RA). We compared 5‐year adverse event (AE) incidence rates (IRs) between patients …
(RA). We compared 5‐year adverse event (AE) incidence rates (IRs) between patients …
Challenges with quality of race and ethnicity data in observational databases
Objective We sought to assess the quality of race and ethnicity information in observational
health databases, including electronic health records (EHRs), and to propose patient self …
health databases, including electronic health records (EHRs), and to propose patient self …
Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme
Objective Tofacitinib is an oral Janus kinase (JAK) inhibitor for the treatment of rheumatoid
arthritis (RA). We report the largest integrated safety analysis of tofacitinib, as of March 2017 …
arthritis (RA). We report the largest integrated safety analysis of tofacitinib, as of March 2017 …
Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL …
AR Balanescu, G Citera, V Pascual-Ramos… - Annals of the …, 2022 - ard.bmj.com
Objectives To characterise infections in patients with rheumatoid arthritis (RA) in ORAL
Surveillance. Methods In this open-label, randomised controlled trial, patients with RA …
Surveillance. Methods In this open-label, randomised controlled trial, patients with RA …
[BOOK][B] Creating contagious commitment: Applying the tipping point to organizational change
A Shapiro - 2010 - books.google.com
Too often, necessary and technically appropriate change initiatives fall short of expected
gains because leaders fail to involve employees and leverage their perspectives. This …
gains because leaders fail to involve employees and leverage their perspectives. This …
Effects of vague probabilities and of vague payoffs on preference: A model comparison analysis
C Gonzalez-Vallejo, A Bonazzi, AJ Shapiro - Journal of Mathematical …, 1996 - Elsevier
Preference orders over gambles having vague probabilities or vague payoffs were
investigated. Riskandworthjudgments were also studied in these two vague conditions. A …
investigated. Riskandworthjudgments were also studied in these two vague conditions. A …
Age-based (< 65 vs≥ 65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the …
KL Winthrop, G Citera, D Gold, D Henrohn… - Annals of the …, 2021 - ard.bmj.com
A randomised, open-label, blinded endpoint post-authorisation safety study (Study
A3921133; NCT02092467; database not locked and subject to change) evaluated the safety …
A3921133; NCT02092467; database not locked and subject to change) evaluated the safety …
Unequal before the law: Men, women and the death penalty
A Shapiro - Am. UJ Gender Soc. Pol'y & L., 2000 - HeinOnline
In a landmark death penalty case, McCleskey v. Kemp, defendant Warren McCleskey, a
Black man, appealed his conviction and death sentence4 on the grounds that Georgia's …
Black man, appealed his conviction and death sentence4 on the grounds that Georgia's …
Overcoming technical and cultural challenges to delivering equitable care for LGBTQ+ individuals in a rural, underserved area
HL Marney, DK Vawdrey, L Warsame… - Journal of the …, 2022 - academic.oup.com
The lesbian, gay, bisexual, transgender, queer, or questioning (LGBTQ+) community is
vulnerable to health-care disparities. Many health-care organizations are working to collect …
vulnerable to health-care disparities. Many health-care organizations are working to collect …